Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             197 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acknowledgements 2009
 64 S1 p. xv-
1 p.
 artikel
2 Author index 2009
 64 S1 p. s77-s82
nvt p.
 artikel
3 Editorial Board 2009
 64 S1 p. i-
1 p.
 artikel
4 EMCTO Invited Speaker disclosures 2009
 64 S1 p. s87-
1 p.
 artikel
5 European Multidisciplinary Conference in Thoracic Oncology Officers and Organization 2009
 64 S1 p. xiv-
1 p.
 artikel
6 10IN ADJUVANT CHEMOTHERAPY IN STAGE IB Pirker, R.
 2009
 64 S1 p. S7-
1 p.
 artikel
7 46IN CHALLENGES AND LIMITATIONS OF INDIVIDUALISED THERAPY Taron, M.
 2009
 64 S1 p. S25-
1 p.
 artikel
8 18IN CHEMORADIOTHERAPY Mornex, F.
 2009
 64 S1 p. S10-
1 p.
 artikel
9 5IN CLINICAL TRIALS BASED ON BIOMARKERS Rosell, R.
 2009
 64 S1 p. S4-
1 p.
 artikel
10 6IN CRITICAL APPRAISAL OF PET AND PET/CT De Wever, W.
 2009
 64 S1 p. S5-
1 p.
 artikel
11 33IN ELDERLY AND CO-MORBID PATIENTS – RADIOTHERAPY Faivre-Finn, C.
 2009
 64 S1 p. S18-
1 p.
 artikel
12 41IN ENDPOINTS IN CLINICAL TRIALS Pirker, R.
 2009
 64 S1 p. S22-
1 p.
 artikel
13 35IN ESMO CLINICAL RECOMMENDATIONS – NSCLC D'Addario, G.
 2009
 64 S1 p. S20-
1 p.
 artikel
14 37IN EUROPEAN TREATMENT GUIDELINES: MESOTHELIOMA Stahel, R.A.
 2009
 64 S1 p. S20-
1 p.
 artikel
15 36IN EUROPEAN TREATMENT GUIDELINES: SMALL CELL LUNG CANCER (SCLC) Sørensen, J.B.
 2009
 64 S1 p. S20-
1 p.
 artikel
16 21IN FIRST-LINE THERAPY Kosmidis, P.A.
 2009
 64 S1 p. S12-S13
2 p.
 artikel
17 16IN FOLLOW-UP: WHY AND HOW Westeel, V.
 2009
 64 S1 p. S9-
1 p.
 artikel
18 17IN HETEROGENEITY OF STAGE III AND ITS IMPLICATION ON TREATMENT Huber, R.M.
 2009
 64 S1 p. S10-
1 p.
 artikel
19 9IN INDIVIDUALISED STAGING: PRACTICAL IMPLICATIONS Spiro, S.
 2009
 64 S1 p. S6-
1 p.
 artikel
20 45IN INDIVIDUALISED THERAPY BASED ON TUMOR FEATURES Besse, B.
 2009
 64 S1 p. S25-
1 p.
 artikel
21 8IN INVASIVE STAGING De Leyn, P.
 2009
 64 S1 p. S5-
1 p.
 artikel
22 31IN ISSUES IN PALLIATIVE CARE Watzke, H.H.
 2009
 64 S1 p. S16-S17
2 p.
 artikel
23 42IN IS THERE A PREFERRED ENDPOINT? Vansteenkiste, J.
 2009
 64 S1 p. S22-
1 p.
 artikel
24 27IN MESOTHELIOMA Scherpereel, A.
 2009
 64 S1 p. S14-S15
2 p.
 artikel
25 1IN MILESTONES IN THE MANAGEMENT OF LUNG CANCER Stahel, R.A.
 2009
 64 S1 p. S2-
1 p.
 artikel
26 7IN MINIMAL INVASIVE STAGING Herth, F.J.F.
 2009
 64 S1 p. S5-
1 p.
 artikel
27 20IN NEW DEVELOPMENTS IN RADIOTHERAPY Dziadziuszko, R.
 2009
 64 S1 p. S11-
1 p.
 artikel
28 2IN NEW FINDINGS IN THE MOLECULAR BIOLOGY OF LUNG CANCER: CLINICAL APPLICATION Gandara, D.
 2009
 64 S1 p. S3-
1 p.
 artikel
29 38IN NSCLC STAGE I AND II Weder, W.
 2009
 64 S1 p. S21-
1 p.
 artikel
30 40IN NSCLC STAGE IV Crinò, L.
 2009
 64 S1 p. S21-
1 p.
 artikel
31 23IN NSCLC STAGE IV: SURGERY IN SELECTED CASES Klepetko, W.
 2009
 64 S1 p. S13-
1 p.
 artikel
32 26IN OTHER NEUROENDOCRINE TUMORS Lim, E.
 2009
 64 S1 p. S14-
1 p.
 artikel
33 29IN PANCOAST TUMORS AND CHEST WALL INVASION Stamatis, G.
 2009
 64 S1 p. S16-
1 p.
 artikel
34 30IN PLEURAL EFFUSION AND AIRWAY MANAGEMENT Vergnon, J.M.
 2009
 64 S1 p. S16-
1 p.
 artikel
35 4IN PREDICTIVE FACTORS IN NSCLC Felip, E.
 2009
 64 S1 p. S3-S4
2 p.
 artikel
36 44IN PREVENTION AND SCREENING Ostoros, G.
 2009
 64 S1 p. S24-
1 p.
 artikel
37 3IN PROGNOSTIC FACTORS IN NON-SMALL CELL LUNG CANCER O'Byrne, K.
 2009
 64 S1 p. S3-
1 p.
 artikel
38 47IN PULMONARY NODULE: DIFFERENTIAL DIAGNOSIS AND BAYESIAN APPROACH Meert, A.P.
 2009
 64 S1 p. S26-
1 p.
 artikel
39 43IN QUALITY OF LIFE AS AN ENDPOINT OF CLINICAL TRIALS Reck, M.
 2009
 64 S1 p. S22-S23
2 p.
 artikel
40 39IN RADIOTHERAPY FOR STAGE III NON-SMALL CELL LUNG CANCER (NSCLC) De Ruysscher, D.
 2009
 64 S1 p. S21-
1 p.
 artikel
41 14IN RADIOTHERAPY WITH CURATIVE INTENT FOR STAGE I AND II NON-SMALL CELL LUNG CANCER De Ruysscher, D.
 2009
 64 S1 p. S8-
1 p.
 artikel
42 22IN SECOND-LINE THERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER Cullen, M.
 2009
 64 S1 p. S13-
1 p.
 artikel
43 25IN SMALL CELL LUNG CANCER Sculier, J.
 2009
 64 S1 p. S14-
1 p.
 artikel
44 11IN STAGING, RESTAGING AND INDUCTION CHEMOTHERAPY IN RESECTABLE N2 DISEASE Massard, G.
 2009
 64 S1 p. S7-
1 p.
 artikel
45 13IN SURGERY Passlick, B.
 2009
 64 S1 p. S8-
1 p.
 artikel
46 19IN SURGERY FOR STAGE III DISEASE Weder, W.
 2009
 64 S1 p. S10-S11
2 p.
 artikel
47 32IN SURGERY IN THE ELDERLY AND CO-MORBID DISEASE Rocco, G.
 2009
 64 S1 p. S18-
1 p.
 artikel
48 15IN SYSTEMIC THERAPY. NON-SMALL CELL LUNG CANCER STAGE I AND II: TREATMENT STANDARDS AND NEW DEVELOPMENT Scagliotti, G.
 2009
 64 S1 p. S8-S9
2 p.
 artikel
49 34IN SYSTEMIC TREATMENT Gridelli, C.
 2009
 64 S1 p. S18-S19
2 p.
 artikel
50 12IN TARGETED THERAPY Paz-Ares, L.
 2009
 64 S1 p. S7-
1 p.
 artikel
51 28IN TUMORS OF THE THYMUS Venuta, F.
 2009
 64 S1 p. S15-
1 p.
 artikel
52 24IN WILL STEREOTACTIC BODY RADIOTHERAPY PROLONG SURVIVAL IN PATIENTS WITH STAGE IV NSCLC? Baumann, P.
 2009
 64 S1 p. S13-
1 p.
 artikel
53 Keyword index 2009
 64 S1 p. s83-s86
nvt p.
 artikel
54 50P ABSTINENCE AND EFFECTIVENESS OF THE SMOKING CESSATION PROJECT: EXPERIENCE OF INDIAN CANCER NGO IN REDUCING THORACIC CANCERS Shankpal, V.P.
 2009
 64 S1 p. S27-S28
2 p.
 artikel
55 185P A CASE OF GIANT SOLITARY FIBROUS TUMOR OF THE PLEURA Dubus, T.
 2009
 64 S1 p. S75-
1 p.
 artikel
56 186P A CASE OF TRACHEOBRONCHOPATHY OSTEOCHONDROPLASTICA Saba, M.
 2009
 64 S1 p. S75-S76
2 p.
 artikel
57 94P ACTIVE PULMONARY TUBERCULOSIS IN LUNG CANCER PATIENTS Adžić, T.N.
 2009
 64 S1 p. S42-
1 p.
 artikel
58 117P ADJUVANT CHEMOTHERAPY BASED ON HISTOCULTURE DRUG RESPONSE ASSAY (HDRA) FOR PATHOLOGICAL STAGE III NON-SMALL CELL LUNG CANCER IMPROVES SURVIVAL Tanahashi, M.
 2009
 64 S1 p. S49-S50
2 p.
 artikel
59 116P ADJUVANT CHEMOTHERAPY IN OPERATED NSCLC PATIENTS (STAGE I, AND II)– A TREND TOWARDS INCREASED USE Kacar-Kukric, V.D.
 2009
 64 S1 p. S49-
1 p.
 artikel
60 158P AN AUDIT OF SURVIVAL IN SMALL CELL LUNG CANCER Al-Terkait, F.
 2009
 64 S1 p. S65-
1 p.
 artikel
61 49P A NICOTINE PATCH IS MORE EFFECTIVE TO QUIT SMOKING WITH TORAZODON THERAPY IN IRAN, ESPECIALLY AMONG WOMEN Heydari, G.
 2009
 64 S1 p. S27-
1 p.
 artikel
62 156P ANTIOXIDANTS AND MARKERS OF OXIDATIVE AND NITROSATIVE STRESS DURING COMBINATION CHEMOTHERAPY FOR SMALL CELL LUNG CANCER Crohns, M.
 2009
 64 S1 p. S65-
1 p.
 artikel
63 135P A PHASE 1B DOSE ESCALATION STUDY OF MP-470 ADMINISTERED CONCURRENTLY WITH STANDARD OF CARE CHEMOTHERAPY IN PATIENTS WITH NSCLC AND SCLC Mita, M.
 2009
 64 S1 p. S57-
1 p.
 artikel
64 61P APPLICATION OF REAL TIME QUANTITATIVE PCR FOR THE ANALYSIS OF CANCER BIOMARKERS Rassi, H.
 2009
 64 S1 p. S31-
1 p.
 artikel
65 166P A RARE CAUSE OF SPONTANEOUS PNEUMOTHORAX: DIFFUSE MIXED MALIGNANT PLEURAL MESOTHELIOMA Dubus, T.
 2009
 64 S1 p. S68-
1 p.
 artikel
66 95 PATTERN, OUTCOMES AND SURVIVAL ANALYSIS OF BRONCHOGENIC CARCINOMA IN A DEVELOPING COUNTRY Marappan, M.
 2009
 64 S1 p. S42-
1 p.
 artikel
67 82P AUTOFLUORESCENCE VIDEOBRONCHOSCOPY (AFI) IMPROVES ASSESSMENT IN CENTRAL LUNG CANCER EXTENSION Zaric, B.
 2009
 64 S1 p. S38-
1 p.
 artikel
68 171P BALANCING CHEMOTHERAPY WITH SUPPORTIVE CARE – THE ROLE OF COMMUNITY NGO HEALTH-SERVICE-PROVIDERS IN IMPROVING QUALITY OF LIFE (QOL) IN LUNG CANCER SUFFERERS Shankpal, P.D.
 2009
 64 S1 p. S69-S70
2 p.
 artikel
69 85P BASELINE AUDIT OF NICE CLINICAL GUIDELINE NO. 24 LUNG CANCER: THE DIAGNOSIS AND TREATMENT OF LUNG CANCER El-Nazer, M.M.
 2009
 64 S1 p. S39-
1 p.
 artikel
70 123P BORDERLINE RESECTIONS AFTER NEO-ADJUVANT TREATMENT: SLEEVE LOBECTOMY VS. PNEUMONECTOMY Toker, A.
 2009
 64 S1 p. S51-S52
2 p.
 artikel
71 77P BRONCHIAL MUCOSA MALIGNANT CYTOLOGIC ALTERATIONS IN PATIENTS AFFECTED BY MODERATE–SEVERE COPD: EVALUATION BY BRONCHIAL BRUSHING Scaramozzino, A.
 2009
 64 S1 p. S36-S37
2 p.
 artikel
72 52P CASE CONTROL STUDY FOR THE ROLE OF CIGARETTE SMOKING IN DEVELOPMENT OF LUNG CANCER Pavlovska, I.
 2009
 64 S1 p. S28-
1 p.
 artikel
73 118P CASE STUDIES OF PULMONARY RESECTION FOR LUNG CANCER IN OCTOGENARIANS Naruke, M.
 2009
 64 S1 p. S50-
1 p.
 artikel
74 138P CHEMOTHERAPY IN STAGE IIIB AND IV NON-SMALL CELL LUNG CANCER: PROGNOSTIC FACTORS Racil, H.
 2009
 64 S1 p. S58-
1 p.
 artikel
75 163P CISPLATIN-RESISTANT CELLS IN HUMAN MALIGNANT PLEURAL MESOTHELIOMA EXHIBIT CANCER STEM CELL CHARACTERISTICS Karoubi, G.
 2009
 64 S1 p. S67-
1 p.
 artikel
76 143P CISPLATINUM PLUS DOCETAXEL (CD) AS INDUCTION CHEMOTHERAPY PRIOR TO RADICAL LOCOREGIONAL (LR) TREATMENT FOR PATIENTS (PTS) WITH STAGE III NON-SMALL CELL LUNG CANCER (NSCLC): RESULTS OF A PROSPECTIVE PHASE II STUDY Berros, J.P.
 2009
 64 S1 p. S59-
1 p.
 artikel
77 165P CLINICAL AND EPIDEMIOLOGICAL APPROACH TO THE MALIGNANT PLEURAL MESOTHELIOMA IN THE REGION OF ORAN Ziane, B.
 2009
 64 S1 p. S67-S68
2 p.
 artikel
78 121P CLINICAL EVALUATION OF A NOVEL 4D IN-VIVO DOSIMETRY SYSTEM FOR LUNG CANCER RADIOTHERAPY Perry, G.
 2009
 64 S1 p. S51-
1 p.
 artikel
79 155P CLINICAL SIGNIFICANCE OF VEGFR-3 POSITIVE CIRCULATING LYMPHATIC/VASCULAR ENDOTHELIAL PROGENITOR CELLS IN SMALL CELL LUNG CANCER Keszthelyi, M.
 2009
 64 S1 p. S64-S65
2 p.
 artikel
80 93P CLINICORADIOGRAPHIC CHARACTERISTICS OF ENDOBRONCHIAL LIPOMAS Milenkovic, B.A.
 2009
 64 S1 p. S42-
1 p.
 artikel
81 55P COMPARISON OF CHEST X-RAY RESULT AMONG TUBERCULOTIC ADMITTED MEN IN MASIH DANESHVARI HOSPITAL ACCORDING TOBACCO EXPOSURE Islampanah, S.
 2009
 64 S1 p. S29-
1 p.
 artikel
82 88P COMPARISON OF PROGNOSTIC VALUE OF THE CURRENT (6TH TNM – 2002) AND FORTHCOMING (7TH TNM – 2009) CLASSIFICATION FOR NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS TREATED WITH RADIATION Kolodziejczyk, M.B.
 2009
 64 S1 p. S40-
1 p.
 artikel
83 109P COMPUTED TOMOGRAPHY (CT) PREDICTS ACCURATELY THE PATHOLOGIC TUMOR SIZE IN STAGE I NON-SMALL CELL LUNG CANCER (NSCLC) Pérez, S.M. Cedrés
 2009
 64 S1 p. S47-
1 p.
 artikel
84 72P C-REACTIVE PROTEIN AND ADENOSINE DEAMINASE MEASUREMENT FOR THE DIFFERENTIATION BETWEEN MALIGNANT AND TUBERCULOUS PLEURAL EFFUSION Moallem, S.A.
 2009
 64 S1 p. S35-
1 p.
 artikel
85 75P CYTOLOGICAL RESULTS OF PATIENTS SUFFERING FROM LUNG CANCER IN A REFERRAL POPULATION IN WESTERN GREECE Lykouras, D.
 2009
 64 S1 p. S36-
1 p.
 artikel
86 76P CYTOLOGICAL RESULTS OF PATIENTS WHO HAVE UNDERGONE BRONCHOSCOPY IN A REFERRAL POPULATION IN WESTERN GREECE Lykouras, D.
 2009
 64 S1 p. S36-
1 p.
 artikel
87 101PD ACCURACY OF PRE-OPERATIVE DIAGNOSIS IN THE MANAGEMENT OF BRONCHIOLOALVEOLAR CARCINOMA – ARE SUBLOBAR RESECTIONS FEASIBLE? Shaker, H.
 2009
 64 S1 p. S44-
1 p.
 artikel
88 100PD ANALYSIS OF RISK FACTORS FOR RADICALLY RESECTED STAGE IB NON-SMALL CELL LUNG CANCER Beshay, M.
 2009
 64 S1 p. S44-
1 p.
 artikel
89 147PD A PHASE II STUDY OF WEEKLY PACLITAXEL PLUS GEMCITABINE AS SECOND-LINE THERAPY IN PATIENTS WITH METASTATIC OR RECURRENT SMALL CELL LUNG CANCER (SCLC) Kim, H.T.
 2009
 64 S1 p. S62-
1 p.
 artikel
90 129PD A SWISS RETROSPECTIVE LUNG CANCER SURVEY ON DOSE CHANGE AND DURATION OF TREATMENT WITH ORAL TYROSINE KINASE INHIBITORS (TKI) Cathomas, R.
 2009
 64 S1 p. S55-
1 p.
 artikel
91 152PD A 10 YEAR FOLLOW-UP OF A SINGLE CENTRE EXPERIENCE WITH INDUCTION CHEMOTHERAPY FOLLOWED BY EXTRAPLEURAL PNEUMONECTOMY FOR MALIGNANT PLEURAL MESOTHELIOMA Opitz, I.
 2009
 64 S1 p. S63-S64
2 p.
 artikel
92 124PD BRAIN METASTASES INFLUENCE SURVIVAL DIFFERENTLY IN THE VARIOUS HISTOLOGICAL SUBTYPES OF NON-SMALL CELL LUNG CANCER Maunglay, S.T.
 2009
 64 S1 p. S53-
1 p.
 artikel
93 104PD CHARLSON CO-MORBIDITY INDEX PREDICTS FOR MORTALITY AFTER STEREOTACTIC BODY RADIOTHERAPY FOR MEDICALLY INOPERABLE EARLY STAGE NON-SMALL CELL LUNG CANCER Kopek, N.
 2009
 64 S1 p. S45-S46
2 p.
 artikel
94 127PD CLINICAL CHARACTERISTICS OF NON-SMALL CELL LUNG CANCER WITH EGFR GENE MUTATIONS IN EXON Miyanaga, A.
 2009
 64 S1 p. S54-
1 p.
 artikel
95 69PD COMPARISON OF 18FDG PET AND 99mTc-MIBI SPECT IN THE DIAGNOSIS OF INDETERMINATE LUNG LESION Fiorelli, A.
 2009
 64 S1 p. S34-
1 p.
 artikel
96 71PD DELAY IN THE MANAGEMENT OF LUNG CANCER Chandra, S.
 2009
 64 S1 p. S34-S35
2 p.
 artikel
97 106PD DOES ELASTIC REGISTRATION ALTER FDG-PET BASED GTVS FOR RADIOTHERAPY PLANNING OF LUNG CANCER? Nestle, U.
 2009
 64 S1 p. S46-
1 p.
 artikel
98 107PD DOSE-PER-FRACTION ESCALATION OF ACCELERATED HYPOFRACTIONATED THREE-DIMENSIONAL CONFORMAL RADIOTHERAPY IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER Kepka, L.
 2009
 64 S1 p. S46-S47
2 p.
 artikel
99 128PD EGFR, KRAS, PIK3CA MUTATIONS AND RESPONSE TO TYROSINE KINASE INHIBITORS (TKIS) IN ADVANCED NSCLC PATIENTS Crinò, L.
 2009
 64 S1 p. S54-
1 p.
 artikel
100 126PD EGFR STATUS OF PRIMARY NSCLC REMAINS UNCHANGED IN LYMPH NODE AND ORGAN METASTASES: AN AUTOPSY STUDY Watzka, S.B.
 2009
 64 S1 p. S54-
1 p.
 artikel
101 178P DELAYS ENCOUNTERED AFTER INITIATION OF CHEMOTHERAPY FOR LUNG CANCER – PRELIMINARY RESULTS OF A PROSPECTIVE STUDY Singh, N.
 2009
 64 S1 p. S73-
1 p.
 artikel
102 130PD ERLOTINIB RELATED TOXICITY IN ELDERLY PATIENTS AFFECTED BY NON-SMALL CELL LUNG CANCER (NSCLC) Palazzo, A.
 2009
 64 S1 p. S55-
1 p.
 artikel
103 154PD ESOPHAGEAL SELF EXPANDABLE METAL STENTS FOR THE PALLIATION OF DYSPHAGIA DUE TO LUNG CANCER Yoruk, Y.
 2009
 64 S1 p. S64-
1 p.
 artikel
104 64PD EVALUATION OF YOUNG AGE EFFECTS ON OUTCOMES IN TOBACCO-INDUCED LUNG CANCER: 8-YEAR EXPERIENCE OF CANCER NGO IN RURAL/TRIBAL INDIA Shankpal, P.D.
 2009
 64 S1 p. S32-
1 p.
 artikel
105 125PD FINAL REPORT OF A RANDOMIZED PHASE II STUDY OF DOCETAXEL/OXALIPLATIN (DO) AND DOCETAXEL (D) IN PREVIOUSLY TREATED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS (PTS). AN ALPE-ADRIA THORACIC ONCOLOGY MULTIDISCIPLINARY GROUP STUDY (ATOM 019) Belvedere, O.
 2009
 64 S1 p. S53-
1 p.
 artikel
106 78P DIAGNOSTIC YIELD OF CLOSED PLEURAL BRUSHING IN MALIGNANT PLEURAL EFFUSION Anzalone, G.E.
 2009
 64 S1 p. S37-
1 p.
 artikel
107 98PD IDENTIFICATION OF TUMOR-ASSOCIATED PROTEINS IN STAGE I LUNG SQUAMOUS CANCER BY PROTEOMICS Zhan, X.
 2009
 64 S1 p. S43-S44
2 p.
 artikel
108 132PD IMMUNE REGULATORY EFFECTS OF SIMVASTATIN IN REGULATORY T CELLS MEDIATED TUMOR IMMUNE TOLERANCE Lee, S.Y.
 2009
 64 S1 p. S56-
1 p.
 artikel
109 48PD IMMUNOHISTOCHEMICAL STUDY OF ANGIOGENESIS AND LYMPHANGIOGENESIS IN NON-SMALL (NSCLC) AND SMALL CELL LUNG CARCINOMAS (SCLC); COULD WE ESTABLISH A NEW PROGNOSTIC FACTOR? Hardavella, G.
 2009
 64 S1 p. S27-
1 p.
 artikel
110 149PD INCIDENCE AND PROGNOSIS OF METASTASES AND LOCAL RECURRENCE IN PATIENTS TREATED SURGICALLY OF CARCINOID LUNG TUMORS Matilla, J.M.
 2009
 64 S1 p. S62-S63
2 p.
 artikel
111 131PD LAPATINIB WITH CHEMOTHERAPY IN FIRST-LINE TREATMENT OF ADVANCED NSCLC IN NEVER SMOKERS OR SELDOM SMOKERS Pandey, R.
 2009
 64 S1 p. S55-S56
2 p.
 artikel
112 67PD LONG-TERM OUTCOMES OF A PILOT CT-SCREENING STUDY FOR LUNG CANCER Veronesi, G.
 2009
 64 S1 p. S33-
1 p.
 artikel
113 96PD LUNG CANCER. CLINICAL CHARACTERISTICS AND 10-YEAR SURVIVAL IN 1856 RESECTED PATIENTS. A POPULATION BASED STUDY Rostad, H.
 2009
 64 S1 p. S43-
1 p.
 artikel
114 63PD LUNG CANCER IN WOMEN IN ST. GALLEN, EASTERN SWITZERLAND. AN ANALYSIS OF SEX-ASSOCIATED DIFFERENCES IN SMOKING HABITS, DISEASE PRESENTATION AND SURVIVAL Frueh, M.
 2009
 64 S1 p. S32-
1 p.
 artikel
115 99PD LYMPHATIC OR VASCULAR INVASION FACTOR IS AN IMPORTANT PROGNOSTIC FACTOR IN PATIENTS WITH PATHOLOGICAL STAGE IA LUNG ADENOCARCINOMA LESS THAN 20mm IN DIAMETER Haneda, H.
 2009
 64 S1 p. S44-
1 p.
 artikel
116 102PD MAGE-A3 ANTIGEN-SPECIFIC CANCER IMMUNOTHERAPEUTIC (ASCI) AS ADJUVANT THERAPY IN RESECTED STAGE IB/II NON-SMALL CELL LUNG CANCER (NSCLC): FROM PROOF-OF-CONCEPT TO PHASE III TRIAL (MAGRIT) Passlick, B.
 2009
 64 S1 p. S45-
1 p.
 artikel
117 153PD MANAGEMENT OF MALIGNANT PLEURAL EFFUSION BY CHRONIC INDWELLING PLEURAL CATHETER Bertolaccini, L.
 2009
 64 S1 p. S64-
1 p.
 artikel
118 103PD MULTIDISCIPLINARY REHABILITATION AFTER LUNG CANCER OPERATION Brocki, B.C.
 2009
 64 S1 p. S45-
1 p.
 artikel
119 151PD MULTIMODALITY THERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA: PLEURECTOMY/DECORTICATION FOLLOWED BY CHEMOTHERAPY WITH CISPLATIN/PEMETREXED AND RADIOTHERAPY Bölükbas, S.
 2009
 64 S1 p. S63-
1 p.
 artikel
120 65PD NEUROENDOCRINE DIFFERENTIATION IN NON-SMALL CELL LUNG CANCER AND ITS RELATION TO PROGNOSIS AND THERAPY Petrović, M.D.
 2009
 64 S1 p. S32-S33
2 p.
 artikel
121 148PD OUTCOMES OF SMALL CELL LUNG CANCER (SCLC) PATIENTS TREATED WITH SECOND-LINE CHEMOTHERAPY (SL): A RETROSPECTIVE ANALYSIS OF 166 PATIENTS Garassino, M.C.
 2009
 64 S1 p. S62-
1 p.
 artikel
122 66PD PRELIMINARY REAL-TIME PCR EVALUATION OF FREE-CIRCULATING PLASMA DNA IN HEALTHY INDIVIDUALS AND PATIENTS WITH RESECTABLE NON-SMALL CELL LUNG CANCER Szpechcinski, A.
 2009
 64 S1 p. S33-
1 p.
 artikel
123 145PD PROGNOSTIC FACTORS FOR SURVIVAL IN PATIENTS (PTS) WITH SMALL CELL LUNG CANCER (SCLC): VALIDATION STUDY OF A PUBLISHED CLASSIFICATION Paesmans, M.
 2009
 64 S1 p. S61-
1 p.
 artikel
124 146PD SELECTIVE NODAL IRRADIATION ON BASIS OF 18FDG-PET SCANS IN LIMITED DISEASE SMALL CELL LUNG CANCER: A PROSPECTIVE STUDY Loon, J. van
 2009
 64 S1 p. S61-
1 p.
 artikel
125 68PD SELF-SELECTION EFFECT IN LUNG CANCER SCREENING OF SMOKERS. A 9.5-YEAR POPULATION-BASED COHORT STUDY IN VARESE – ITALY Dominioni, L.
 2009
 64 S1 p. S33-S34
2 p.
 artikel
126 105PD SEQUENTIAL CHEMORADIATION AND RADIATION ALONE IN THE TREATMENT OF INOPERABLE, LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) AND CORRELATION OF TUMOUR ERCC1 WITH SURVIVAL Davda, R.
 2009
 64 S1 p. S46-
1 p.
 artikel
127 70PD “STRAIGHT TO TEST APPROACH” IN THE DIAGNOSTIC PATHWAY OF LUNG CANCER PATIENTS Sathyamurthy, R.
 2009
 64 S1 p. S34-
1 p.
 artikel
128 97PD THE INFLUENCE OF GENDER AND SMOKING STATUS ON OVERALL SURVIVAL IN SURGICALLY RESECTED NON-SMALL CELL LUNG CANCER Al-Alao, B.
 2009
 64 S1 p. S43-
1 p.
 artikel
129 150PD THE VALUE OF VOLUMETRIC MEASUREMENT OF MALIGNANT PLEURAL MESOTHELIOMA (MPM) TO ASSESS THE THERAPY RESPONSE Tutic, M.
 2009
 64 S1 p. S63-
1 p.
 artikel
130 168P EFFICIENCY OF SMALL BORED CATHETER THORACOSTOMY IN DIFFERENT TYPES OF PLEURAL EFFUSION Navari, K.
 2009
 64 S1 p. S68-S69
2 p.
 artikel
131 181P ENDOBRONCHIAL METASTASIS FROM ORAL FIBROSARCOMA 13 YEARS AFTER TREATMENT OF PRIMARY TUMOR Rahimi-Rad, M.H.
 2009
 64 S1 p. S74-
1 p.
 artikel
132 122P ENDOBRONCHIAL RADIOTHERAPY IN THE TREATMENT OF TRACHEA MALIGNANT TUMORS Chernichenko, A.V.
 2009
 64 S1 p. S51-
1 p.
 artikel
133 139P ERLOTINIB VERSUS GEFITINIB TREATMENT FOR NON-SMALL CELL LUNG CANCER (NSCLC): A SINGLE INSTITUTION EXPERIENCE IN KOREA Lee, S.Y.
 2009
 64 S1 p. S58-
1 p.
 artikel
134 157P EVALUATION OF AN INFLAMMATION-BASED PROGNOSTIC SCORE (GPS) IN SCLC PATIENTS Wojcik, E.
 2009
 64 S1 p. S65-
1 p.
 artikel
135 74P EVALUATION OF FLOW CYTOMETRIC IMMUNOPHENOTYPING AND DNA ANALYSIS FOR DETECTION OF MALIGNANT CELLS IN SEROSAL CAVITY FLUIDS Sayed, D.
 2009
 64 S1 p. S35-S36
2 p.
 artikel
136 172P EXAMINING THE CROSS-CULTURAL VALIDITY OF THE EORTC QLO-LC13 LUNG CANCER SPECIFIC MODULE IN TURKISH POPULATION Ataman, F.
 2009
 64 S1 p. S70-
1 p.
 artikel
137 57P FACTOR XIII TRANSGLUTAMINASE IN NON-SMALL CELL LUNG CANCER Kim, J.H.
 2009
 64 S1 p. S30-
1 p.
 artikel
138 114P HYPOFRACTIONATED RADIOTHERAPY WITH STEREOTACTIC LOCALIZATION IN EARLY STAGE NON-SMALL CELL LUNG CANCER (NSCLC) Salvi, F.
 2009
 64 S1 p. S48-S49
2 p.
 artikel
139 162P ILK EXPRESSION IN MALIGNANT PLEURAL MESOTHELIOMA CAN BE PREDICTIVE OF SURVIVAL Watzka, S.B.
 2009
 64 S1 p. S67-
1 p.
 artikel
140 108P ILK STATUS AND THE PROGRESSION OF EARLY-STAGE NSCLC: A PILOT STUDY Watzka, S.B.
 2009
 64 S1 p. S47-
1 p.
 artikel
141 58P ILK STATUS IN THE PRIMARY TUMOR IS A SIGNIFICANT RISK FACTOR FOR THE DEVELOPMENT OF DISTANT METASTASES IN NSCLC Watzka, S.B.
 2009
 64 S1 p. S30-
1 p.
 artikel
142 144P INDUCTION CHEMOTHERAPY FOLLOWED BY CONCOMITANT CHEMORADIOTHERAPY IN LOCALLY ADVANCED UNRESECTABLE NON-SMALL CELL LUNG CANCER Goswami, J.
 2009
 64 S1 p. S60-
1 p.
 artikel
143 182P LARGE CHEST WALL RESECTION FOR THE PRIMARY CHEST WALL NEOPLASM – TECHNIQUE AND RESULTS Peštál, A.
 2009
 64 S1 p. S74-
1 p.
 artikel
144 142P LOW-DOSE RADIOTHERAPY AND CONCURRENT PEMETREXED FOR ADVANCED NON-SMALL CELL LUNG CANCER WITH PROGRESSIVE DISEASE Meduri, B.
 2009
 64 S1 p. S59-
1 p.
 artikel
145 53P LUNG CANCER – DOES SMOKING STATUS MAKE A DIFFERENCE? Devaraj, U.
 2009
 64 S1 p. S28-S29
2 p.
 artikel
146 184P MALT LYMPHOMA OF THE LUNG (TWO CASES) Ortaköylü, G.
 2009
 64 S1 p. S75-
1 p.
 artikel
147 59P MARKERS OF PROLIFERATION ACTIVITY IN NON-SMALL CELL LUNG CANCER Vasutova, I.
 2009
 64 S1 p. S30-S31
2 p.
 artikel
148 79P MASS SPECTROMETRIC IDENTIFICATION OF NOVEL PROTEOMIC BIOMARKERS OF NON-SMALL CELL LUNG CANCER Streeper, R.
 2009
 64 S1 p. S37-
1 p.
 artikel
149 164P MORBIDITY, MORTALITY, AND MEAN SURVIVAL AFTER TOTAL OR SUBTOTAL PLEURECTOMY FOR MALIGNANT PLEURAL MESOTHELIOMA Fiorelli, A.
 2009
 64 S1 p. S67-
1 p.
 artikel
150 176P MULTIMODALITY TREATMENTS IN LOCALLY ADVANCED THYMOMAS Hassan, M.A.
 2009
 64 S1 p. S72-
1 p.
 artikel
151 80P MULTIPLEX IMMUNOASSAY ASSAY ANALYSIS OF DIFFERENTIALLY EXPRESSED BIOMARKERS OF NON-SMALL CELL LUNG CANCER Izbicka, E.
 2009
 64 S1 p. S37-
1 p.
 artikel
152 86P NET OF THE LUNG AND MISSING INFORMATION: IS AN ITALIAN REGISTRY USEFUL? Valmadre, G.
 2009
 64 S1 p. S39-S40
2 p.
 artikel
153 170P PAIN MANAGMENT IN LUNG CANCER Racil, H.
 2009
 64 S1 p. S69-
1 p.
 artikel
154 174P PALLIATIVE CARE IN PATIENTS WITH ENDOBRONCHIAL CARCINOMA BY ELECTROCAUTERY AND STENT PLACEMENT Saenghirunvattana, S.
 2009
 64 S1 p. S70-S71
2 p.
 artikel
155 167P PEMETREXED IN MESOTHELIOMA: POLONORD GROUP EXPERIENCE Bertolini, A.
 2009
 64 S1 p. S68-
1 p.
 artikel
156 62P PLATINUM-BASED CHEMOTHERAPY IN LUNG CANCER AFFECTS THE EXPRESSION OF CERTAIN BIOMARKERS INCLUDING ERCC Moldvay, J.
 2009
 64 S1 p. S31-
1 p.
 artikel
157 136P PLATINUM BASED CHEMOTHERAPY IN STAGE IIIB AND IV NON-SMALL CELL LUNG CANCER (NSCLC) – THE EFFECT ON SURVIVAL Mobarek, N.A.
 2009
 64 S1 p. S57-
1 p.
 artikel
158 169P PLEURODESIS FOR MALIGNANT PLEURAL EFFUSION USING IODOPOVIDONE: A MULTICENTRE EXPERIENCE Mallik, S.
 2009
 64 S1 p. S69-
1 p.
 artikel
159 112P POST-PNEUMONECTOMY CAVITY: IS THERE STILL A CAVITY? Stavroulias, D.
 2009
 64 S1 p. S48-
1 p.
 artikel
160 183P PRIMARY SYNOVIAL SARCOMA OF THE LUNG: A CASE SERIES Watzka, S.B.
 2009
 64 S1 p. S74-S75
2 p.
 artikel
161 87P PRIMARY TUMOURS OF THE RIBS; EXPERIENCE OF 78 PATIENTS FROM A SINGLE CENTER Kaya, S.
 2009
 64 S1 p. S40-
1 p.
 artikel
162 134P PROGNOSTIC FACTORS FOR SURVIVAL IN ADULT PATIENTS (PTS) WITH METASTATIC NON-SMALL CELL LUNG CANCER AFTER THE FIRST-LINE CHEMOTHERAPY Belbaraka, R.
 2009
 64 S1 p. S56-S57
2 p.
 artikel
163 73P PROTEOME ANALYSIS OF MALIGNANT PLEURAL EFFUSION Lee, K.Y.
 2009
 64 S1 p. S35-
1 p.
 artikel
164 133P PULMONARY METASTASECTOMY – A SINGLE INSTITUTION EXPERIENCE Dilege, S.
 2009
 64 S1 p. S56-
1 p.
 artikel
165 160P RADIOLOGICAL PATTERNS IN PATIENTS WITH SMALL CELL LUNG CANCER (SCLC) IN MID-WESTERN IRELAND Quintyne, K.I.
 2009
 64 S1 p. S66-
1 p.
 artikel
166 81P ROLE OF SOME TOOLS IN THE DIAGNOSIS OF PLEURAL EFFUSION Opanasenko, M.
 2009
 64 S1 p. S38-
1 p.
 artikel
167 111P SHORT-TERM AND LONG-TERM RESULTS OF SURGICAL MANAGEMENT IN ELDERLY LUNG CANCER PATIENTS (OVER 70 YEARS): OUR EXPERIENCE Bazarov, D.V.
 2009
 64 S1 p. S48-
1 p.
 artikel
168 51P SOCIOECONOMIC DIFFERENCES IN THE PREVALENCE OF ACTIVE AND PASSIVE TOBACCO SMOKING AMONG CANCER PATIENTS IN UZBEKISTAN Usmanova, G.T.
 2009
 64 S1 p. S28-
1 p.
 artikel
169 161P SOLUBLE MESOTHELIN RELATED PROTEIN (SMRP) IN MALIGNANT PLEURAL MESOTHELIOMA (MPM) Azim Jr, H.A.
 2009
 64 S1 p. S66-
1 p.
 artikel
170 89P STAGING OF LUNG CANCER. CAN INTEGRATED PET/CT REPLACE A DIAGNOSTIC CT FOR THE DETECTION OF BRAIN METASTASES? Wever, W. De
 2009
 64 S1 p. S40-S41
2 p.
 artikel
171 115P STEREOTACTIC RADIOTHERAPY AS BOOST FOR LUNG CANCER: WHICH HISTOLOGIC RESULT? Laslo, L.D.
 2009
 64 S1 p. S49-
1 p.
 artikel
172 159P SYSTEMATIC REVIEW OF TREATMENT OF ADVANCED PULMONARY CARCINOIDS Himpe, U.
 2009
 64 S1 p. S66-
1 p.
 artikel
173 84P THE ASSESSMENT OF CLINICAL EFFICIENCY OF VIDEO ASSISTED THORACIC SURGERY (VATS) IN ONCOLOGIC PATIENTS WITH A SYNDROME OF PULMONARY DISSEMINATION Orlov, S.S.
 2009
 64 S1 p. S39-
1 p.
 artikel
174 60P THE EFFECT OF STEROIDS ON THE HSP SYSTEM OF THE CELLS Gál, K.
 2009
 64 S1 p. S31-
1 p.
 artikel
175 179P THE OUTCOMES OF SUPERSELECTIVE ANGIOGRAPHIC CHEMOEMBOLISATION OF LUNG METASTASES Kopeika, U.
 2009
 64 S1 p. S73-
1 p.
 artikel
176 180P THE ROLE OF RESIDUAL TUMOR RESECTION IN THE MANAGEMENT OF METASTATIC NONSEMINOMATOUS GERM CELL CANCER OF TESTICULAR ORIGIN Schirren, J.
 2009
 64 S1 p. S73-S74
2 p.
 artikel
177 140P THE ROLE OF THORACIC SURGERY IN TREATMENT OF PULMONARY METASTASIS Veselý, M.
 2009
 64 S1 p. S58-
1 p.
 artikel
178 113P THE THIRD PRIMARY–THE SECOND METACHRONOUS LUNG CANCER IN THE SAME PATIENT Kaya, S.
 2009
 64 S1 p. S48-
1 p.
 artikel
179 173P THE USE OF OXYGEN THERAPY DURING PALLIATIVE CHEMOTHERAPY FOR LUNG CANCER Badalyan, L.
 2009
 64 S1 p. S70-
1 p.
 artikel
180 92P THORACIC HEMANGIOPERICYTOMA: OUR EXPERIENCE IN DIAGNOSIS AND SURGICAL TREATMENT Opanasenko, M.
 2009
 64 S1 p. S41-S42
2 p.
 artikel
181 91P THORACIC NEUROGENIC TUMORS: OUR EXPERIENCE IN THE DIAGNOSIS AND SURGICAL TREATMENT Opanasenko, M.
 2009
 64 S1 p. S41-
1 p.
 artikel
182 175P TRACHEAL CANCER: PROGNOSTIC FACTORS AND ROLE OF RADIATION THERAPY Hetnal, M.
 2009
 64 S1 p. S72-
1 p.
 artikel
183 137P TREATMENT OF ADVANCED NSCLC (STAGE IIIB AND IV) WITH LOW DOSE GEMCITABINE AND CARBOPLATIN – INDIAN EXPERIENCE Narayanan, P.
 2009
 64 S1 p. S57-
1 p.
 artikel
184 141P TRICHOMEGALY OF THE EYELASH INDUCED BY ERLOTINIB THERAPY Iacovelli, R.
 2009
 64 S1 p. S59-
1 p.
 artikel
185 119P TUMOR MOVEMENTS DETECTED BY MULTI-SLICE CT-BASED IMAGE FUSION IN THE RADIOTHERAPY OF LUNG CANCER Kovacs, A.
 2009
 64 S1 p. S50-
1 p.
 artikel
186 177P USE OF A SIMPLIFIED GERIATRIC EVALUATION IN THORACIC ONCOLOGY Cudennec, T.
 2009
 64 S1 p. S72-S73
2 p.
 artikel
187 110P VATS LOBECTOMY – INCREASING ROLE IN GENERAL THORACIC AND CANCER SURGERY Kullamaa, A.
 2009
 64 S1 p. S47-S48
2 p.
 artikel
188 54P VENOUS THROMBOEMBOLISM AND LUNG CANCER Racil, H.
 2009
 64 S1 p. S29-
1 p.
 artikel
189 56P VESICULAR S-NITROSOGLUTATHIONE REDUCTASE TRAFFICS TO THE NUCLEUS IN LATE-STAGE MITOSIS AND MAY BE A NEW TUMOR MARKER Marozkina, N.V.
 2009
 64 S1 p. S29-S30
2 p.
 artikel
190 83P VIDEO MEDIASTINOSCOPY, DOES IT HAVE A REAL RISK? Beshay, M.
 2009
 64 S1 p. S38-
1 p.
 artikel
191 120P VOLUMETRIC RESPONSE ANALYSIS DURING CHEMORADIATION AS PREDICTIVE TOOL FOR OPTIMIZING TREATMENT STRATEGY IN LOCALLY ADVANCED UNRESECTABLE NSCLC Bral, S.J.
 2009
 64 S1 p. S50-
1 p.
 artikel
192 90P WHICH METHOD SHOULD BE USED TO DETERMINE BONE METASTASIS OF LUNG CANCER? Ömeroğlu, G.
 2009
 64 S1 p. S41-
1 p.
 artikel
193 The European Respiratory Society (ERS) 2009
 64 S1 p. xi-
1 p.
 artikel
194 The European Society for Medical Oncology (ESMO) 2009
 64 S1 p. ix-
1 p.
 artikel
195 The European Society for Therapeutic Radiology and Oncology (ESTRO) 2009
 64 S1 p. ix-
1 p.
 artikel
196 The European Society of Thoracic Surgeons (ESTS) 2009
 64 S1 p. xi-
1 p.
 artikel
197 Welcome to the European Multidisciplinary Conference in Thoracic Oncology Pirker, Robert
 2009
 64 S1 p. S1-
1 p.
 artikel
                             197 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland